Vanda Pharmaceuticals: Pay

Vanda Pharmaceuticals paid its 5 named executives $9.6M in total in FY2025 (Dec). CEO Mihael H. Polymeropoulos, M.D. was paid $3.9M of that.

Pay$100 in the stock at the end of FY20 → $67

CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

Mihael H. Polymeropoulos, M.D.President, Chief Executive Officer and Chairman of the Board


FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)							Not disclosed
FY2021 (Dec)							Not disclosed

5 years

Joakim WijkstromSenior Vice President, Chief Marketing Officer


FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)							Not disclosed
FY2021 (Dec)							Not disclosed

5 years

Timothy WilliamsSenior Vice President, General Counsel and Secretary


FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)							Not disclosed
FY2021 (Dec)							Not disclosed

5 years

Kevin MoranSenior Vice President, Chief Financial Officer and Treasurer


FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)							Not disclosed
FY2021 (Dec)							Not disclosed

5 years

Gunther BirznieksSenior Vice President, Business Development


FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)							Not disclosed
FY2021 (Dec)							Not disclosed

5 years

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.